| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.5 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |